Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SREC-I (scavenger receptor class F member 1) is a type I transmembrane protein belonging to the class F family of scavenger receptors[3][1][5]. It recognizes and binds a broad spectrum of ligands, including acetylated and oxidized forms of LDL, apoptotic bodies, and heat shock proteins, facilitating their endocytosis and degradation[2][3][1][5]. Expressed notably by endothelial cells, macrophages, and dendritic cells, SREC-I participates in lipid metabolism, antigen presentation, innate and adaptive immune responses, and cellular adhesion[1][2][3][5]. Its interaction with TLRs and capacity for cross-presentation of antigens position it as an important link between immunity and homeostasis, with disease associations in inflammation, infection, cancer, and atherosclerosis[1][2][3].
Drugs (if developed) would likely act via modulation of: Ligand binding and scavenging (blocking or enhancing interaction with modified LDL or HSPs); Immune modulation (affecting antigen presentation, TLR signaling).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Scavenger receptor class F member 1 (SCARF1).